Artemisinin resistance is rising in East Africa—leaving anti-malarials at risk of failure. Resistance to the main drug in front-line malaria treatments is becoming more widespread across East Africa, according to new research by Imperial College London.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: Resistance to the main drug in front-line malaria treatments is becoming more widespread across East Africa, according to new research by Imperial College London. The study, published in The Lancet Infectious Diseases, maps the rise in artemisinin resistance in the region and suggests one of the safeguards built into these treatments is being eroded.
- Ponto de atenção: artemisinin.
- Ponto de atenção: resistance.
- Ponto de atenção: rising.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.